As a component of the clinically proven arthritis pain remedy, Arthri-Zen, Juniper combines with goldenrod, dandelion, meadowsweet, and willow, to provide remarkably effective pain relief, even for severe pain sufferers.

Juniper has been used since pre-Biblical times in perfumery and cosmetics, beverage flavoring, and as a seasoning for cooking.

Juniper has many uses as an herbal. It is high in natural insulin analogues, and supports the pancreas. It is used for urinary infections, and for difficulty in urination.

Native American healers have historically used Juniper in preparing pain relieving poultices for enflamed joints.

Compounds in Juniper that block production of positive slow fiber (C-fiber) neurotransmitters (NT's), increase production of negative C-fiber NT's, and block production of prostacyclin synthetase (an enzyme required to synthesize an inflammatory prostaglandin) explain why it is used to ease pain and inflammation in the joints or muscles in cases of rheumatism and arthritis. Studies have clearly shown anti-inflammatory behavior through inhibition of PAF (platelet activation factor), as well as antiviral and antiseptic properties.

Volatile oil from Juniper berries has long enjoyed a reputation as a diuretic because certain components of the volatile oils act as local nephron irritants and increase glomerular filtration without increasing loss of electrolytes. The dual action of blocking certain aspects of the pain signal transmission route and decreasing inflammatory chemical concentrations in the tissues are key to its function in alleviating symptoms. Juniper berries make an excellent antiseptic in conditions such as cystitis and as a steam inhalant in the management of bronchitis. The bitter action aids digestion and eases flatulent colic.

As a component of the clinically proven arthritis pain remedy, Arthri-Zen, Juniper combines with goldenrod, dandelion, meadowsweet, and willow, to provide remarkably effective pain relief, even for severe pain sufferers.

While just ten years ago it was estimated that arthritis affected 42 million Americans ?or one in five adults ?new data released by the Centers for Disease Control (CDC) show the disease is much more common than previously thought. The CDC now puts the number of adults in the U.S. with arthritis and chronic jointproblems at 70 million ?or one in three adults.

5 Arthri-Zen Relief?has been the subject of two clinical trials in the past, both showing it is effective at relieving the crippling pain of arthritis. The current 30-day trial, which was conducted by the independent Fenestra Research Labs, was undertaken to add to the scientific research supporting the product.

Seventy five subjects with extreme arthritis pain were recruited for the study. To qualify, subjects had to have daily pain at level 9 to 10 on a scale of 1-10. Fifty of the participants took Arthri-Zen Relief? 25took placebo.

The results were dramatic. Subjects taking placebo had no change in pain level during the study. By day 4, however, only 53.1 percent of those taking the Arthri-Zen Relief?were still at pain level 9-10. Threedays later, that figure dropped to 6.1 percent, and by day 7, it was 0 percent. On the tenth day, a full 85.7 percent of patients were reporting no pain at all. And by day 14, every single one of the people in the testgroup was completely pain-free. No rescue medications were allowed over the course of the 30-day trial ?which means the effects were solely due to the Arthri-Zen Relief?

RZN Nutraceuticals founder, CEO and chief scientist Mark Lubin is thrilled with the results of the study, but he can抰 say he抯 entirely surprised. He developed the product for his own personal use after 13surgeries and countless prescription and OTC drugs failed him in his battle against a debilitating case of osteoarthritis. Today, he is completely mobile and pain-free, thanks to Arthri-Zen Relief? With three clinical trials supporting the product抯 efficacy, he certainly won抰 be the only one. RZN Nutraceuticals is located in Miami, Florida. RZN Nutraceutical founder, CEO and chief scientist Mark Lubin is a biomedical engineer who has 12 U.S. patents issued or pending for biomedical andtechnical innovations. Arthri-Zen Relief?grew out of Lubin抯 work to alleviate his own terrible arthritis pain and free himself from the ravaging toll pharmaceuticals were taking on his body. He later developed Migra-Zen Relief Plus?by making precise alterations to the Arthri-Zen Relief?formula. Both productsfeature a proprietary blend of herbs in a patent-pending delivery system. They are available in natural food stores nationwide and through the company抯 website: http://www.rznnutra.com.

For more information on Migra-Zen Relief Plus?or any of the three Arthri-Zen Relief?formulations,please visit http://www.rznnutra.com or call Robert Hunt at 904-276-8324.